Holdings Surged Nvidia's Chip: Arm Stock Outlook 2026
A new AI chip announcement from Nvidia sparked a powerful rally in Arm Holdings. This guide breaks down the catalysts...
Week Ahead Indices To Watch
This page presents Week Ahead Indices To Watch, outlining upcoming index movements and strategic considerations for the week ahead.
23,536 articles
At Some Point You’ve Got to Make Money: AI Skeptic Warns
A Goldman Sachs AI skeptic warns the market’s patience may be running thin as OpenAI and Anthropic gear up for mega-I...
BWET’s 1,645% Gain Rests on One Event That Could Reverse
BWET has surged on a geopolitically driven spike in tanker rates. The rally hinges on one event, and a calm could tri...
Could This Tiny Stock Spark Millionaire Returns in AI
Small AI plays can jump from obscurity to headlines fast. This guide analyzes the risks and potential rewards, with p...
Global Manufacturing Weakens, Here’s Copper ETF Outlook
Copper-focused ETFs have outperformed in recent months, but a softer global factory backdrop could test demand. Here'...
Merlin CTO Autonomy Rebuild of Aviation Foundations
Merlin's chief technology officer argues that autonomous systems could redefine aviation safety and national security...
Defense Contractor Nobody Wanted Turns AI Darling Play
An overlooked defense contractor pivots to AI, turning years of skepticism into a rising star in enterprise AI and de...
Wall Street Analyst Thinks Viking Stock Could Soar 188%
A wall street analyst thinks Viking Therapeutics could unlock substantial upside if VK2735 delivers in Phase 3. Learn...
Apple Just Delivered News That Impacts AI Stocks and Winners
When Apple speaks at WWDC, markets listen. This article breaks down how Apple Just Delivered News about AI strategy, ...
World Ticket Scammers Targeting Fans: How to Stay Safe
Fans chasing World Cup tickets face a growing threat from world ticket scammers targeting. This guide explains how th...
Musk’s SpaceX Trillion-Dollar Revenue Goal Faces Scrutiny
SpaceX pursues a bold $1 trillion revenue target by 2031, a goal that has investors and analysts weighing how feasibl...
AbbVie Stock Will $300: Timing and Risks to Watch
AbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status